CELERA, MEDAREX COLLABORATE ON THERAPEUTIC ANTIBODY

A A

Celera Genomics, an Applera Corporation business, and Medarex Inc. have entered into a collaboration to discover and develop human antibodies for the potential treatment of multiple cancer indications.

Biospectrum Asia (http://www.biospectrumasia.com/content/260606OTH1000.asp)